Effect of methotrexate in post-operative wound healing in rheumatoid patients undergoing foot and ankle surgery

ISRCTN ISRCTN86123456
DOI https://doi.org/10.1186/ISRCTN86123456
Secondary identifying numbers N0280141217
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
12/04/2011
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Nick Emms
Scientific

Department of Orthopaedics
Wirral Hospital NHS Trust
Arrowe Park Road
Upton
Wirral
CH49 5PE
United Kingdom

Phone +44 (0)151 678 5111
Email nick.emms@ukonline.co.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesDoes methotrexate affect post-operative wound healing in rheumatoid patients undergoing foot and ankle surgery?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Foot and ankle
InterventionGroup A: continuous methotrexate therapy for two weeks during perioperative period
Group B: omit methotrexate therapy for two weeks during perioperative period

Added September 2008: trial stopped due to poor recruitment.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)methotrexate
Primary outcome measure1. Rate of wound infection
2. Patient pain levels
Secondary outcome measuresNot provided at time of registration
Overall study start date01/05/2004
Completion date01/05/2005
Reason abandoned (if study stopped)Poor recruitment

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsSample of 200 patients in each group.
Key inclusion criteriaRheumatoid patients on methotrexate therapy undergoing foot and ankle surgery.
Key exclusion criteria1. Ongoing use of other immunosuppression agents.
2. Localised infection pre-operatively.
Date of first enrolment01/05/2004
Date of final enrolment01/05/2005

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Orthopaedics
Wirral
CH49 5PE
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Wirral Hospitals NHS Trust (UK), NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan